MA5-15810 targets OLIG2 in IF, IHC, and WB applications and shows reactivity with Human samples.
The MA5-15810 immunogen is purified recombinant fragment of human OLIG2 expressed in E. Coli.
MA5-15810 detects OLIG2 which has a predicted molecular weight of approximately 32kDa.
This gene encodes a basic helix-loop-helix transcription factor which is expressed in oligodendroglial tumors of the brain. The protein is an essential regulator of ventral neuroectodermal progenitor cell fate. The gene is involved in a chromosomal translocation t(14;21)(q11.2;q22) associated with T-cell acute lymphoblastic leukemia. Its chromosomal location is within a region of chromosome 21 which has been suggested to play a role in learning deficits associated with Down syndrome. Tissue specificity: Expressed in the brain, in oligodendrocytes. Strongly expressed in oligodendrogliomas, while expression is weak to moderate in astrocytomas. Expression in glioblastomas highly variable.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: basic domain, helix-loop-helix protein, class B, 1; bHLHb1; BHLHB1, OLIGO2, PRKCBP2, RACK17, bHLHe19, basic domain, helix-loop-helix protein, class B, 1; bHLHe19; Class B basic helix-loop-helix protein 1; Class E basic helix-loop-helix protein 19; human protein kinase C-binding protein RACK17; Oligo2; Oligodendrocyte transcription factor 2; oligodendrocyte-specific bHLH transcription factor 2; Protein kinase C-binding protein 2; Protein kinase C-binding protein RACK17
Gene Aliases: BHLHB1; BHLHE19; OLIG2; OLIGO2; PRKCBP2; RACK17
UniProt ID: (Human) Q13516
Entrez Gene ID: (Human) 10215